Feline lentivirus evolution in cross-species infection reveals extensive G-to-A mutation and selection on key residues in the viral polymerase

Journal of Virology

Volumn 80, Issue 6, 2006, Pages 2728-2737

  Poss, Mary ^a   Ross, Howard A ^b   Painter, Sally L ^a   Holley, David C ^a   Terwee, Julie A ^c   Vandewoude, Sue ^c   Rodrigo, Allen ^b  

^a UNIVERSITY OF MONTANA   (United States)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTIDINE DEAMINASE; DNA POLYMERASE; GUANINE; RNA DIRECTED DNA POLYMERASE;

AMINO ACID SEQUENCE; ARTICLE; ENVELOPE GENE; EVALUATION; FELINE IMMUNODEFICIENCY VIRUS; GENE MUTATION; GENE SEQUENCE; HOST RANGE; LENTIVIRINAE; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PUMA; RNA EDITING; SEQUENCE ANALYSIS; STRUCTURAL GENE; VIREMIA; VIRUS GENOME; VIRUS INFECTION;

ANIMALS; ANIMALS, DOMESTIC; CAT DISEASES; CATS; EVOLUTION, MOLECULAR; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; GENES, POL; IMMUNODEFICIENCY VIRUS, FELINE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY; PUMA; SELECTION (GENETICS); SEQUENCE ANALYSIS, DNA; SPECIES SPECIFICITY;

FELINE IMMUNODEFICIENCY VIRUS; FELINE LENTIVIRUSES; FELIS CATUS; LENTIVIRUS; PUMA CONCOLOR;

EID: 33644773579     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.80.6.2728-2737.2006     Document Type: Article

References (60)

1. Beer, B., J. Denner, C. R. Brown, S. Norley, J. zur Megede, C. Coulibaly, R. Plesker, S. Holzammer, M. Baier, V. M. Hirsch, and R. Kurth. 1998. Simian immunodeficiency virus of African green monkeys is apathogenic in the newborn natural host. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18:210-220.
2. Biek, R., A. G. Rodrigo, D. Holley, A. Drummond, C. R. Anderson, Jr., H. A. Ross, and M. Poss. 2003. Epidemiology, genetic diversity, and evolution of endemic feline immunodeficiency virus in a population of wild cougars. J. Virol. 77:9578-9589.
3. Bogerd, H. P., B. P. Doehle, H. L. Wiegand, and B. R. Cullen. 2004. A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor. Proc. Natl. Acad. Sci. USA 101:3770-3774.
4. Broussard, S. R., S. I. Staprans, R. White, E. M. Whitehead, M. B. Feinberg, and J. S. Allan. 2001. Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease. J. Virol. 75:2262-2275.
5. Carpenter, M. A., and S. J. O'Brien. 1995. Coadaptation and immunodeficiency virus: lessons from the Felidae. Curr. Opin. Genet. Dev. 5:739-745.
6. Charneau, P., and F. Clavel. 1991. A single-stranded gap in human immunodeficiency virus unintegrated linear DNA defined by a central copy of the polypurine tract. J. Virol. 65:2415-2421.
7. Conticello, S. G., R. S. Harris, and M. S. Neuberger. 2003. The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. Curr. Biol. 13:2009-2013.
8. Daszak, P., A. A. Cunningham, and A. D. Hyatt. 2000. Emerging infectious diseases of wildlife-threats to biodiversity and human health. Science 287: 443-449.
9. Ding, J., K. Das, C. Tantillo, W. Zhang, A. D. Clark, Jr., S. Jessen, X. Lu, Y. Hsiou, A. Jacobo-Molina, K. Andries, et al. 1995. Structure of HIV-1 reverse transcriptase in a complex with the non-nucleoside inhibitor alpha-APA R 95845 at 2.8 A resolution. Structure 3:365-379.
10. Escutenaire, S., and P. P. Pastoret. 2000. Hantavirus infections. Rev. Sci. Technol. 19:64-78.
11. Goncalves, J., and M. Santa-Marta. 2004. HIV-1 Vif and APOBEC3G: multiple roads to one goal. Retrovirology 1:28.
12. Goode, M., and A. G. Rodrigo. 2004. Using PEBBLE for the evolutionary analysis of serially sampled molecular sequences, p. 6.8.1-6.8.26. In A. D. Baxevanis (ed.), Current protocols in bioinformatics. Wiley, Hoboken, N.J.
13. Hahn, B. H., G. M. Shaw, K. M. De Cock, and P. M. Sharp. 2000. AIDS as a zoonosis: scientific and public health implications. Science 287:607-614.
14. Harris, R. S., K. N. Bishop, A. M. Sheehy, H. M. Craig, S. K. Petersen-Mahrt, I. N. Watt, M. S. Neuberger, and M. H. Malim. 2003. DNA deamination mediates innate immunity to retroviral infection. Cell 113:803-809.
15. Holmes, E. C. 2001. On the origin and evolution of the human immunodeficiency virus (HIV). Biol. Rev. Camb. Philos. Soc. 76:239-254.
16. Huang, H., R. Chopra, G. L. Verdine, and S. C. Harrison. 1998. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science 282:1669-1675.
17. Jacobo-Molina, A., J. Ding, R. G. Nanni, A. D. Clark, Jr., X. Lu, C. Tantillo, R. L. Williams, G. Kamer, A. L. Ferris, P. Clark, et al. 1993. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. Proc. Natl. Acad. Sci. USA 90:6320-6324.
18. Jetzt, A. E., H. Yu, G. J. Klarmann, Y. Ron, B. D. Preston, and J. P. Dougherty. 2000. High rate of recombination throughout the human immunodeficiency virus type 1 genome. J. Virol. 74:1234-1240.
19. Lochelt, M., F. Romen, P. Bastone, H. Muckenfuss, N. Kirchner, Y. B. Kim, U. Truyen, U. Rosler, M. Battenberg, A. Saib, E. Flory, K. Cichutek, and C. Munk. 2005. The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein. Proc. Natl. Acad. Sci. USA 102:7982-7987.
20. Mahy, B. W., and C. C. Brown. 2000. Emerging zoonoses: crossing the species barrier. Rev. Sci. Technol. 19:33-40.
21. Mangeat, B., P. Turelli, S. Liao, and D. Trono. 2004. A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action. J. Biol. Chem. 279:14481-14483.
22. Mansky, L. M., and H. M. Temin. 1995. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J. Virol. 69:5087-5094.
23. Marin, M., K. M. Rose, S. L. Kozak, and D. Kabat. 2003. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat. Med. 9:1398-1403.
24. Martinez, M. A., J. P. Vartanian, and S. Wain-Hobson. 1994. Hyper-mutagenesis of RNA using human immunodeficiency virus type 1 reverse transcriptase and biased dNTP concentrations. Proc. Natl. Acad. Sci. USA 91:11787-11791.
25. Miller, R. J., J. S. Cairns, S. Bridges, and N. Sarver. 2000. Human immunodeficiency virus and AIDS: insights from animal lentiviruses. J. Virol. 74:7187-7195.
26. Morin, T., F. Guiguen, B. A. Bouzar, S. Villet, T. Greenland, D. Grezel, F. Gounel, K. Gallay, C. Garnier, J. Durand, T. Alogninouwa, L. Mselli-Lakhal, J. F. Mornex, and Y. Chebloune. 2003. Clearance of a productive lentivirus infection in calves experimentally inoculated with caprine arthritis- encephalitis virus. J. Virol. 77:6430-6437.
27. Mounts, A. W., H. Kaur, U. D. Parashar, T. G. Ksiazek, D. Cannon, J. T. Arokiasamy, L. J. Anderson, and M. S. Lye. 2001. A cohort study of health care workers to assess nosocomial transmissibility of Nipah virus, Malaysia, 1999. J. Infect. Dis. 183:810-813.
28. Navarro, F., and N. R. Landau. 2004. Recent insights into HIV-1 Vif. Curr. Opin. Immunol. 16:477-482.
29. Nunes-Araujo, F. R., S. D. Nishioka, I. B. Ferreira, A. Suzuki, R. F. Bonito, and M. S. Ferreira. 1999. Absence of interhuman transmission of hantavirus pulmonary syndrome in Minas Gerais, Brazil: evidence from a serological survey. Clin. Infect. Dis. 29:1588-1589.
30. Ogunbodede, E. O. 2004. HIV/AIDS situation in Africa. Int. Dent. J. 54: 352-360.
31. Packer, C., S. Altizer, M. Appel, E. Brown, J. Martenson, S. J. O'Brien, M. Roelke-Parker, R. Hofmann-Lehmann, and H. Lutz. 1999. Viruses of the Serengeti: patterns of infection and mortality in African lions. J. Anim. Ecol. 68:1161-1178.
32. Parashar, U. D., L. M. Sunn, F. Ong, A. W. Mounts, M. T. Arif, T. G. Ksiazek, M. A. Kamaluddin, A. N. Mustafa, H. Kaur, L. M. Ding, G. Othman, H. M. Radzi, P. T. Kitsutani, P. C. Stockton, J. Arokiasamy, H. E. Gary, Jr., and L. J. Anderson. 2000. Case-control study of risk factors for human infection with a new zoonotic paramyxovirus, Nipah virus, during a 1998-1999 outbreak of severe encephalitis in Malaysia. J. Infect. Dis. 181:1755-1759.
33. Pini, N., S. Levis, G. Calderon, J. Ramirez, D. Bravo, E. Lozano, C. Ripoll, S. St. Jeor, T. G. Ksiazek, R. M. Barquez, and D. Enria. 2003. Hantavirus infection in humans and rodents, northwestern Argentina. Emerg. Infect. Dis. 9:1070-1076.
34. Pond, S. L., and S. D. Frost. 2005. Datamonkey: rapid detection of selective pressure on individual sites of codon alignments. Bioinformatics 21:2531-2533.
35. Pond, S. L., and S. D. Frost. 2005. Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol. Biol. Evol. 22:1208-1222.
36. Posada, D., and K. A. Crandall. 1998. MODELTEST: testing the model of DNA substitution. Bioinformatics 14:817-818.
37. Rambaut, A., and N. C. Grassly. 1997. Seq-Gen: an application for the Monte Carlo simulation of DNA sequence evolution along phylogenetic trees. Comput. Appl. Biosci. 13:235-238.
38. Rhodes, T., H. Wargo, and W. S. Hu. 2003. High rates of human immunodeficiency virus type 1 recombination: near-random segregation of markers one kilobase apart in one round of viral replication. J. Virol. 77:11193-11200.
39. Sawyer, S. L., M. Emerman, and H. S. Malik. 2004. Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol. 2:E275.
40. Schrofelbauer, B., D. Chen, and N. R. Landau. 2004. A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif). Proc. Natl. Acad. Sci. USA 101:3927-3932.
41. Schrofelbauer, B., Q. Yu, and N. R. Landau. 2004. New insights into the role of Vif in HIV-1 replication. AIDS Rev. 6:34-39.
42. Sheehy, A. M., N. C. Gaddis, and M. H. Malim. 2003. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat. Med. 9:1404-1407.
43. Shriner, D., A. G. Rodrigo, D. C. Nickle, and J. I. Mullins. 2004. Pervasive genomic recombination of HIV-1 in vivo. Genetics 167:1573-1583.
44. Simon, J. H., D. L. Miller, R. A. Fouchier, M. A. Soares, K. W. Peden, and M. H. Malim. 1998. The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: a role for Vif in determining virus host range and cross-species transmission. EMBO J. 17:1259-1267.
45. Swofford, D. L. 1999. PAUP*. Phylogenetic analysis using parsimony (*and other methods), 4.3 ed. Sinauer Associates, Sunderland, Mass.
46. Takeuchi, H., S. Kao, E. Miyagi, M. A. Khan, A. Buckler-White, R. Plishka, and K. Strebel. 2005. Production of infectious SIVagm from human cells requires functional inactivation but not viral exclusion of human APOBEC3G. J. Biol. Chem. 280:375-382.
47. Terwee, J. A., J. K. Yactor, K. S. Sondgeroth, and S. Vandewoude. 2005. Puma lentivirus is controlled in domestic cats after mucosal exposure in the absence of conventional indicators of immunity. J. Virol. 79:2797-2806.
48. Thompson, J. D., T. J. Gibson, F. Plewniak, F. Jeanmougin, and D. G. Higgins. 1997. The ClustalX windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25:4876-4882.
49. VandeWoude, S., C. A. Hageman, S. J. O'Brien, and E. A. Hoover. 2002. Nonpathogenic lion and puma lentiviruses impart resistance to superinfection by virulent feline immunodeficiency virus. J. Acquir. Immune Defic. Syndr. 29:1-10.
50. VandeWoude, S., S. O'Brien, and E. Hoover. 1997. Infectivity of lion and puma lentiviruses for domestic cats. J. Gen. Virol. 78:795-800.
51. VandeWoude, S., S. J. O'Brien, K. Langelier, W. D. Hardy, J. P. Slattery, E. E. Zuckerman, and E. A. Hoover. 1997. Growth of lion and puma lentiviruses in domestic cat cells and comparisons with FIV. Virology 233:185-192.
52. Vartanian, J. P., M. Henry, and S. Wain-Hobson. 2002. Sustained G→A hypermutation during reverse transcription of an entire human immunodeficiency virus type 1 strain Vau group O genome. J. Gen. Virol. 83:801-805.
53. Vartanian, J. P., U. Plikat, M. Henry, R. Mahieux, L. Guillemot, A. Meyerhans, and S. Wain-Hobson. 1997. HIV genetic variation is directed and restricted by DNA precursor availability. J. Mol. Biol. 270:139-151.
54. Whitwam, T., M. Peretz, and E. Poeschla. 2001. Identification of a central DNA flap in feline immunodeficiency virus. J. Virol. 75:9407-9414.
55. Wolfe, N. D., W. M. Switzer, J. K. Carr, V. B. Bhullar, V. Shanmugam, U. Tamoufe, A. T. Prosser, J. N. Torimiro, A. Wright, E. Mpoudi-Ngole, F. E. McCutchan, D. L. Birx, T. M. Folks, D. S. Burke, and W. Heneine. 2004. Naturally acquired simian retrovirus infections in central African hunters. Lancet 363:932-937.
56. Xu, H., E. S. Svarovskaia, R. Barr, Y. Zhang, M. A. Khan, K. Strebel, and V. K. Pathak. 2004. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion. Proc. Natl. Acad. Sci. USA 101:5652-5657.
57. Yang, Z. 1997. PAML: a program package for phylogenetic analysis by maximum likelihood. Comput. Appl. Biosci. 13:555-556.
58. Yang, Z., W. S. Wong, and R. Nielsen. 2005. Bayes empirical Bayes inference of amino acid sites under positive selection. Mol. Biol. Evol. 22:1107-1118.
59. Yu, Q., R. Konig, S. Pillai, K. Chiles, M. Kearney, S. Palmer, D. Richman, J. M. Coffin, and N. R. Landau. 2004. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nat. Struct. Mol. Biol. 11:435-442.
60. Zhang, H., B. Yang, R. J. Pomerantz, C. Zhang, S. C. Arunachalam, and L. Gao. 2003. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424:94-98.